Prognosis of pancreatic cancer with Trousseau syndrome: a systematic review of case reports in Japanese literature

被引:0
作者
Munehiro Wakabayashi
Yoshinori Kikuchi
Kazuhisa Yamaguchi
Takahisa Matsuda
机构
[1] Toho University,Division of Gastroenterology and Hepatology, Department of Internal Medicine (Omori), Faculty of Medicine, School of Medicine
[2] Toho University,Department of Clinical Oncology, Faculty of Medicine
来源
Journal of the Egyptian National Cancer Institute | / 35卷
关键词
Pancreatic cancer; Trousseau syndrome; Prognosis; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
Trousseau syndrome is a paraneoplastic syndrome associated with a risk of poor prognosis. We reviewed the survival time and prognosis of patients with Trousseau syndrome. We identified 40 cases from 28 reports of Trousseau syndrome due to pancreatic cancer. We analyzed 20 cases based on reports providing sufficient information on the stage/location of pancreatic cancer and survival time after Trousseau syndrome. The median survival time was 2.0 months. There was no statistical difference between performance status (PS) 0–1 and PS 4, stages I–III and IV, and pancreatic head and body/tail. However, statistically significant differences were noted between the median survival time of patients who continued treatment for pancreatic cancer even after Trousseau syndrome and those who discontinued treatment (P = 0.005). Although only a small number of cases were analyzed in this study, the results indicated that patients with pancreatic cancer who developed Trousseau syndrome had a poor prognosis, and chemotherapy should be continued, if possible.
引用
收藏
相关论文
共 211 条
[1]  
Graus F(1985)Cerebrovascular complications in patients with cancer Medicine (Baltim) 64 16-35
[2]  
Rogers LR(1984)Nonbacterial thrombotic endocarditis as a cause of cerebral and myocardial infarction Jpn Circ J 48 1000-1006
[3]  
Posner JB(2016)Cancer-associated stroke—clinical management of Trousseau’s syndrome Nihon Kessen Shiketsu Gakkaishi 27 18-28
[4]  
Kuramoto K(2007)Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 632-634
[5]  
Matsushita S(2004)Stroke in patients with cancer: incidence and etiology Neurology 62 2025-2030
[6]  
Yamanouchi H(2007)Mucin-producing adenocarcinoma of the pancreas accompanied by Trousseau syndrome A case report Neurol Med 67 547-551
[7]  
Nogawa S(2008)A case of Trousseau syndrome caused by pancreatic cancer with liver metastasis during chemotherapy Jpn J Cancer Clin 54 701-705
[8]  
Khorana AA(2008)Trousseau syndrome with recurrent cerebral infarction A case report Neurol Med 69 490-493
[9]  
Francis CW(2009)A case of trousseau syndrome involving cerebral infarction as the first manifestation of concealed pancreatic cancer Intern Med 104 589-592
[10]  
Culakova E(2010)Trousseau syndrome accompanied by pancreatic adenocarcinoma A case report Neurol Med 72 194-197